A laboratory study summarized in a Scientific Reports abstract reports that a newly characterized antimicrobial cyclic peptide, abbreviated AMCP, reduced lipid synthesis in SZ95 sebocytes, killed two bacterial species, and suppressed several inflammatory mediators in cultured skin cells. The findings describe effects in experimental systems and do not establish that AMCP improves acne in people.
At a concentration of 20 µg/mL, AMCP reduced dihydrotestosterone- and linoleic acid-induced lipid synthesis in SZ95 sebocytes by 40.0% and 29.1%, respectively. The peptide also had minimum inhibitory and minimum bactericidal concentrations of 0.5 µg/mL against Cutibacterium acnes and 1.0 µg/mL against Staphylococcus aureus, indicating bactericidal activity in the reported bacterial assays.
In HaCaT keratinocytes and SZ95 sebocytes, AMCP suppressed IL-6, IL-8, IL-1β, TNF-α and PGE₂ in a concentration-dependent manner. The abstract also reports that AMCP promoted keratinocyte migration, increased expression of the epidermal differentiation genes FLG, IVL, Claudin-1 and KRT1, and reduced KLK7 expression. Together, these results support activity across lipid synthesis, antibacterial activity, inflammation and cellular measures relevant to skin biology.
The study additionally evaluated topical dermal delivery. Combining AMCP with 2% propylene glycol and 0.1% sodium surfactin increased cumulative permeation fivefold at eight hours under the reported test conditions. The supplied abstract does not describe testing in people or report clinical outcomes, and it does not provide information on selectivity, safety, formulation stability or whether the compound was tested in animals elsewhere in the full study. AMCP therefore remains a multitarget candidate whose laboratory effects require further evaluation before any conclusion about clinical benefit can be made.
Subject of Research: Laboratory evaluation of an antimicrobial cyclic peptide for multi-target activity in acne-related cellular and bacterial models
Article Title: An antimicrobial cyclic peptide with multitarget efficacy for acne
Article References: Yu, N., Guo, G., Zhang, L., He, T., Zhang, M., Wang, J., Wang, J., Yao, R., Wang, G.-L., & Wang, J. (2026). An antimicrobial cyclic peptide with multitarget efficacy for acne. Scientific Reports. https://doi.org/10.1038/s41598-026-75285-7
Image Credits: AI Generated
DOI: 10.1038/s41598-026-75285-7
Keywords: antimicrobial cyclic peptide, AMCP, acne vulgaris, sebocytes, keratinocytes, Cutibacterium acnes, inflammation, topical delivery, laboratory study, antimicrobial, cyclic, peptide
News Source: Denise Maddox. (October 20, 2026). Antimicrobial cyclic peptide shows multi-target effects in laboratory acne models. Scienmag.
